RETINOPATHY OF PREMATURITY DISEASE OF THE EYE SCREENING OF PATIENTS ON OUR NEONATAL UNIT
A Contract Award Notice
by AIREDALE NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £30K
- Sector
- HEALTH
- Published
- 27 Apr 2026
- Delivery
- not specified
- Deadline
- n/a
Related Terms
Location
AIREDALE GENERAL HOSPITAL<br/>SKIPTON ROAD<br/>STEETON <br/>BD20 6TD
2 buyers
- Airedale NHS Trust Kieghley
1 supplier
- Calderdale & Huddersfield Solutions Huddersfield
Description
**PSR DIRECT AWARD A AWARD NOTICE**RETINOPATHY OF PREMATURITY DISEASE OF THE EYE SCREENING OF PATIENTS ON OUR NEONATAL UNIT.VALUE OF THE CONTRACT £30,000.FOR THE PERIOD 01/04/2026 TO 31/03/2027 WITH THE OPTION TO EXTEND FOR 2 PERIODS OF 12 MONTHS.
Total Quantity or Scope
**PSR DIRECT AWARD A AWARD NOTICE**RETINOPATHY OF PREMATURITY DISEASE OF THE EYE SCREENING OF PATIENTS ON OUR NEONATAL UNIT.VALUE OF THE CONTRACT £30,000.FOR THE PERIOD 01/04/2026 TO 31/03/2027 WITH THE OPTION TO EXTEND FOR 2 PERIODS OF 12 MONTHS. PROVISION OF ROP SCREENING OF PATIENTS TO BE DELIVERED AS AND WHEN REQUIRED BY THE CONTRACTING AUTHORITY. THE CONTRACT VALUE IS ESTIMATED AND WILL VARY BASED ON ACTIVITY LEVELS. THE INITIAL CONTRACT TERM WILL RUN FROM 01/04/2026 TO 31/03/2027, WITH THE OPTION FOR THE AUTHORITY TO EXTEND FOR UP TO TWO ADDITIONAL PERIODS OF 12 MONTHS EACH.THIS CONTRACT HAS NOW BEEN AWARDEDNO CONFLICTS OF INTEREST WERE IDENTIFIED DURING THE PROCUREMENT PROCESS.NO SUBCONTRACTING IS EXPECTEDTHIS IS AN EXISITING SERVICE WITH AN AWARD TO AN EXISITING PROVIDER
Award Detail
| 1 | Calderdale & Huddersfield Solutions (Huddersfield)
|
Award Criteria
| No realistic alternative provider | 100.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Award on basis of price and quality.
Legal Justification
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.'
Other Information
**PSR DIRECT AWARD A AWARD NOTICE**RETINOPATHY OF PREMATURITY DISEASE OF THE EYE SCREENING OF PATIENTS ON OUR NEONATAL UNIT.VALUE OF THE CONTRACT £30,000.FOR THE PERIOD 01/04/2026 TO 31/03/2027 WITH THE OPTION TO EXTEND FOR 2 PERIODS OF 12 MONTHS. PROVISION OF ROP SCREENING OF PATIENTS TO BE DELIVERED AS AND WHEN REQUIRED BY THE CONTRACTING AUTHORITY. THE CONTRACT VALUE IS ESTIMATED AND WILL VARY BASED ON ACTIVITY LEVELS. THE INITIAL CONTRACT TERM WILL RUN FROM 01/04/2026 TO 31/03/2027, WITH THE OPTION FOR THE AUTHORITY TO EXTEND FOR UP TO TWO ADDITIONAL PERIODS OF 12 MONTHS EACH.THIS CONTRACT HAS NOW BEEN AWARDEDNO CONFLICTS OF INTEREST WERE IDENTIFIED DURING THE PROCUREMENT PROCESS.NO SUBCONTRACTING IS EXPECTEDTHIS IS AN EXISITING SERVICE WITH AN AWARD TO AN EXISITING PROVIDER THIS IS A PROVIDER SELECTION REGIME (PSR) CONFIRMATION OF CONTRACT AWARD NOTICE. THIS CONTRACT HAS BEEN AWARDED UNDER THE HEALTH CARE SERVICES (PROVIDER SELECTION REGIME) REGULATIONS 2023. FOR THE AVOIDANCE OF DOUBT, THE PROVISIONS OF THE PUBLIC CONTRACTS REGULATIONS 2015 DO NOT APPLY TO THIS AWARD.'AWARD DECISION-MAKERS;JAMIL AHMEDKATHERYN HOOPERTHIS CONTRACT HAS NOW BEEN AWARDEDNO CONFLICTS OF INTEREST WERE IDENTIFIED DURING THE PROCUREMENT PROCESS.NO SUBCONTRACTING IS EXPECTEDTHIS IS AN EXISITING SERVICE WITH AN AWARD TO AN EXISITING PROVIDERBased on the Authorities assessment and PSR decision making process AHNHSFT intends to award a contract to an existing provider following Direct Award Process A (only one capable provider) under the Provider Selection Regime (PSR).The authority is proposing a new contract to replace the existing contract at the end of its term and the proposed contracting arrangements are not changing considerably.AHNHSFT is of the view that the existing provider is the only capable provider provider due to essential clinical, operational or pathway interdependencies, and no realistic alternative exists to meet the Authority’s specific requirements.Direct Award Processes B (unrestricted patient choice) does not apply
Reference
- FTS 037834-2026